Adenovirus-mediated VEGF165 gene transfer enhances wound healing by promoting angiogenesis in CD1 diabetic mice

Gene Therapy

Volumn 9, Issue 19, 2002, Pages 1271-1277

  Romano Di Peppe, S ^a   Mangoni, A ^b   Zambruno, G ^a   Spinetti, G ^a   Melillo, G ^a   Napolitano, M ^a   Capogrossi, M C ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

Author keywords

Diabetes; Gene therapy; VEGF; Wound healing

Indexed keywords

ADENOVIRUS VECTOR; ANESTHETIC AGENT; BETA LACTAMASE; BROMETHOL; GROWTH FACTOR; SODIUM CHLORIDE; STREPTOZOCIN; VASCULOTROPIN; WOUND HEALING PROMOTING AGENT;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXCISION; GENE THERAPY; GENE TRANSFER; MALE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SKIN ULCER; STREPTOZOCIN DIABETES; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT; VIRUS REPLICATION; WOUND CLOSURE; WOUND HEALING;

ADENOVIRIDAE; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIAL GROWTH FACTORS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GRANULATION TISSUE; LYMPHOKINES; MALE; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; SKIN; TRANSDUCTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; WOUND HEALING;

ADENOVIRIDAE; ANIMALIA;

EID: 0036792590     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301798     Document Type: Article

References (46)

1. Clark RAF. Biology of dermal wound repair. Dermatol Clin 1993; 11: 647-666.
2. Folkman J. Angiogenesis: initiation and control. Ann NY Acad Sci 1982; 401: 212-227.
3. Robinson CJ et al. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci 2001; 5: 853-865.
4. Leung DW et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-1309.
5. Keck PJ et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989; 8: (246) 1309-1312.
6. Richard DE et al. Angiogenesis: how a tumor adapts to hypoxia. Biochem Biophys Res Commun 1999; 266: 718-722.
7. Nissen N et al. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 1998; 152: 1445-1452.
8. Detmar M et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 1994; 180: 1141-1146.
9. Detmar M et al. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Invest Dermatol 1995; 105: 44-50.
10. Ballaun C et al. Human keratinocytes express the three major splice forms of vascular endothelial growth factor. J Invest Dermatol 1995; 104: 7-10.
11. Frank S et al. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 1995; 270: 12607-12613.
12. Detmar M. Molecular regulation of angiogenesis in the skin. J Invest Dermatol 1996; 106: 207-208.
13. Detmar M et al. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 1998; 111: 1-6.
14. Kishimoto J et al. In vivo detection of human vascular endothelial growth factor promoter activity in transgenic mouse skin. Am J Pathol 2000; 157: 103-110.
15. Matsuda H et al. Role of nerve growth factor in cutaneous wound healing: accelerating effects in normal and healing-impaired diabetic mice. J Exp Med 1998; 187: 297-306.
16. Bitar MS. Glucocorticoid dynamics and impaired wound healing in diabetes mellitus. Am J Pathol 1998; 152: 547-554.
17. Brown DL et al. Differential expression and localization of insulin-like growth factors I and II in cutaneous wounds of diabetic and nondiabetic mice. Am J Pathol 1997; 151: 715-724.
18. Miller AD. Human gene therapy comes of age. Nature 1992; 357: 455-460.
19. Mulligan RC. The basic science of gene therapy. Science 1993; 260: 926-932.
20. Bajocchi G et al. Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nat Genet 1993; 3: 229-234.
21. Setoguchi Y et al. Ex vivo and in vivo gene transfer to the skin using replication-deficient recombinant adenovirus vectors. J Invest Dermatol 1994; 102: 415-421.
22. Boulton AJ. The diabetic foot: a global view. Diabet Metab Res Rev 2000; 16 (Suppl. 1): S2-S5.
23. Zimny S et al. Early detection of microcirculatory impairment in diabetic patients with foot at risk. Diabetes Care 2001; 24: 1810-1814.
24. Woon Ji-Won. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus. Ann NY Acad Sci 2001; 928: 200-211.
25. Rivard A et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 1999; 154: 355-363.
26. Coleman DL et al. Obese and diabetes: two mutant genes causing diabetes- obesity syndrome in mice. Diabetologia 1978; 14: 141-148.
27. Inaba M et al. Partial protection of 1 alpha-hydroxyvitamin D3 against the development of diabetes induced by multiple low-dose streptozotocin injection in CD-1 mice. Metabolism 1992; 41: 631-635.
28. Corral CJ et al. Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing. Arch Surg 1999; 134: 200-205.
29. Lorenzi M et al. High glucose prolongs cell-cycle traversal of cultured human endothelial cells. Diabetes 1987; 36: 1261-1267.
30. Curcio F et al. Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: new insights on the pathophysiological mechanisms of diabetic vascular complications. In Vitro Cell Dev Biol 1992; 28: 787-790.
31. Brown LF et al. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992; 176: 1375-1379.
32. Peters KG et al. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 1993; 90: 8915-8919.
33. Greenhalgh DG et al. PDGF and FGF stimulate wound healing in the genetically diabetic mice. Am J Pathol 1990; 136: 1235-1246.
34. Robson MC et al. The safety and effect of topically applied recombinant basic fibroblast growth factor on the healing of chronic pressure sores. Ann Surg 1992; 216: 401-406.
35. Marques da Costa R. Double-blind randomized placebo-controlled trial of the use of granulocyte-macrophage colony-stimulating factor in chronic leg ulcers. Am J Surg 1997; 173: 165-168.
36. Safi Jr J et al. Adenovirus-mediated acidic fibroblast growth factor gene transfer induces angiogenesis in the nonischemic rabbit heart. Microvasc Res 1999; 58: 238-249.
37. Rosengart TK et al. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 1999; 100: 468-474.
38. Sun L et al. Transfection with aFGF cDNA improves wound healing. J Invest Dermatol 1997; 108: 313-318.
39. Yamasaki K et al. Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. J Clin Invest 1998; 101: 967-971.
40. Liechty KW et al. Adenoviral-mediated overexpression of platelet-derived growth factor-B corrects ischemic impaired wound healing. J Invest Dermatol 1999; 113: 375-383.
41. Vale PR et al. Left ventricular electromechanical mapping to asses efficacy of phVEGF (165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation 2000; 102: 965-974.
42. Leek RD et al. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J Pathol 2000; 190: 430-436.
43. Muhlhauser J et al. VEGF165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo. Circ Res 1995; 77: 1077-1086.
44. Sai P et al. Effects of cyclosporin on autoimmune diabetes induced in mice by streptozotocin: beta cell-toxicity and rebound of insulitis after cessation of treatment. Diabet Metab 1988; 14: 455-462.
45. Gowdak LH et al. Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia. Circulation 2000; 102: 565-571.
46. Anversa P, Capasso JM. Loss of intermediate-sized coronary arteries and capillary proliferation after left ventricular failure in rats. Am J Physiol 1991; 260: H1552-Hl560.